Healthcare & Wellness

Medication-Assisted Treatment (MAT) Agreement

Controlled-substance treatment agreement for patients receiving buprenorphine (Suboxone/Subutex), methadone, or naltrexone for opioid use disorder or alcohol use disorder, covering drug screening, single-prescriber policy, diversion, and recovery expectations.

๐Ÿ“„ 1 signer๐Ÿ“… 30-day expiry๐Ÿท Healthcare & Wellness๐Ÿ”– consent, addiction-medicine, mat, buprenorphine, suboxone, methadone, naltrexone, opioid-use-disorder, treatment-agreement, controlled-substance

About this template

The Medication-Assisted Treatment (MAT) Agreement is a ready-to-use healthcare & wellness template you can send for signature in minutes. It is written for 1 signer (patient) and, by default, expires 30 days after it is sent if left unsigned. It covers consent, addiction medicine, mat, buprenorphine, suboxone, methadone. Like every Abundera Sign template it is a convenience draft structured for ESIGN Act and UETA compliance, not a substitute for legal advice. Each signed copy is sealed with PAdES-LTA digital signatures, dual RFC 3161 timestamps, and a tamper-evident evidence package in WORM storage.

Document Preview

# Medication-Assisted Treatment (MAT) Agreement > **Important โ€” not medical advice.** For use by a licensed provider; tailor to the patient, your protocols, and state law. **Provider / Practice:** ___________ **Patient Name:** ___________ **Date of Birth:** ___________ **Medical Record Number:** ___________ --- ## 1. Purpose of This Agreement Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. MAT is evidence-based medicine โ€” not a substitute for recovery, but a critical tool that reduces cravings, prevents withdrawal, lowers the risk of relapse, and dramatically reduces overdose mortality. Because MAT medications are controlled substances (buprenorphine, methadone) or require clinical oversight (naltrexone), this Treatment Agreement establishes the mutual obligations of the patient and the prescribing practice. Both parties must follow these terms to maintain safe, effective, legally compliant treatment. --- ## 2. Diagnosis and Medication Prescribed **Primary Diagnosis:** ___________ **MAT Medication:** ___________ **Dose / Formulation:** ___________ **Prescribing / Treating Clinician:** ___________ **Dispensing Pharmacy (if applicable):** ___________ --- ## 3. What This Medication Does ### Buprenorphine (Suboxone, Subutex, Sublocade, Probuphine)

Fields (18)

provider name
text ยท required
patient name
text ยท required
date of birth
date ยท required
mrn
text ยท required
diagnosis
select ยท required
mat medication
select ยท required
dose formulation
text ยท required
prescribing clinician
text ยท required
pharmacy name
text ยท required
uds frequency
text ยท required
benzo disclosure
select ยท required
naloxone status
select ยท required
counseling requirement
text ยท required
initial duration
text ยท required
after hours contact
text ยท required
counselor name
text ยท required
governing state
select ยท required
patient printed name
text ยท required

Related Healthcare & Wellness templates

All 159 Healthcare & Wellness templates โ†’ ย ยทย  Browse all templates โ†’

Send this template with cryptographic proof

Every signed document gets PAdES-LTA digital signatures, dual RFC 3161 timestamps, and a tamper-evident evidence package sealed in WORM storage.

Try the DemoView PricingFounding Member โ€” 50% Off